Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 20;22(7):1239–1246. doi: 10.1002/ejhf.1758

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

EJHF-1758-FIG-0002-c — Results from network analysis showing protein–protein interactions for empirically identified markers (orange), predicted markers (blue) and associated pathways (green). ACP5, acid phosphatase 5, Tartrate Resistant; ALCAM, activated leukocyte cell adhesion molecule; CCL2, chemokine (C‐C motif) ligand 2; CCL15, chemokine (C‐C motif) ligand 15; CHI3L1, chitinase‐3‐like protein 1; EGFR, epidermal growth factor receptor; GRN, granulin; HSPG2, heparan sulfate proteoglycan 2; LDLR, low‐density lipoprotein receptor; LGALS3, galectin‐3; MMP2, matrix metalloproteinase 2; MMP3, matrix metalloproteinase 3; PCSK9, proprotein convertase subtilisin/kexin type 9; PDGFA, platelet‐derived growth factor subunit A; SPP1, secreted phosphoprotein 1; TIMP4, tissue inhibitor of metalloproteinase 4.